Glomerular permselectivity in early stages of overt diabetic nephropathy
about
Increased urine IgM excretion predicts cardiovascular events in patients with type 1 diabetes nephropathy.Microalbuminuria in diabetes mellitus.Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy.Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.Urinary markers of glomerular injury in diabetic nephropathyDiabetic nephropathy: the proteinuria hypothesis.An Extended Minimal Physiologically Based Pharmacokinetic Model: Evaluation of Type II Diabetes Mellitus and Diabetic Nephropathy on Human IgG Pharmacokinetics in RatsPreventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.Biophysics of glomerular filtration.Psammomys obesus, a particularly important animal model for the study of the human diabetic nephropathyValsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension.Increased glomerular permeability in patients with nephropathia epidemica caused by Puumala hantavirus.Mechanisms of glomerular albumin filtration and tubular reabsorption.Reduced glomerular size selectivity in late streptozotocin-induced diabetes in rats: application of a distributed two-pore model.Effects of valsartan and amlodipine on cardiorenal protection in Japanese hypertensive patients: the Valsartan Amlodipine Randomized Trial.Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART.Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.Glomerular pore size corresponding to albumin molecular size, an explanation for underlying structural pathology leading to albuminuria at nanolevel.Effects of ACE inhibition and angiotensin II receptor blockade on glomerular basement membrane protein excretion and charge selectivity in type 2 diabetic patients.
P2860
Q33490238-E276913D-48C9-427F-A56D-A317D94EBC95Q34004759-AE520045-A304-46FB-AB7F-3385768F5EEEQ34926825-8D6A450D-62A7-451F-9009-4270ADCA63C7Q35925533-CD089DDA-F289-4A67-8BB6-902CE9418DF8Q35974945-FC16000C-AB13-47AA-8C88-402B5792E183Q36061335-37878986-4960-4815-B8E7-3B58ABC5EAE8Q36232508-9E01222B-9380-4E1D-B084-05843C8F140DQ36392987-3A19C75C-EB77-470E-A9E6-98606FAAD5CAQ37364926-A53567C3-EB22-4F63-97F2-44001439F443Q38110744-4831A6BF-4100-486C-A99D-61E81739C347Q38738365-9D5831F8-2213-4CBD-A299-66E6C7B1DDA6Q40309957-4F6B7502-A1D9-4EB6-A255-2CA2129FCED4Q40589337-B2077B76-2A12-4A5C-B63D-44EC00042C8CQ42044140-A3CF2900-F997-4E75-9095-9DAC69922638Q42530764-38B4023E-F249-4319-AA55-37A701891E3EQ43492164-34BA2D05-2926-40A3-8C92-EA032B4EBD3AQ44224759-BE2C4B5D-55B2-4FBE-8373-AE0F3B839129Q44695731-3767949C-BAB4-46EC-9E76-255D49FD671FQ44737055-25247429-CB6F-4D43-925E-3429C02588CBQ47346405-13AA08FF-DA94-488C-88BE-2230372C8C33Q50716050-4FD1CAE8-CC60-4450-9A59-B25B0FC398E6
P2860
Glomerular permselectivity in early stages of overt diabetic nephropathy
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Glomerular permselectivity in early stages of overt diabetic nephropathy
@ast
Glomerular permselectivity in early stages of overt diabetic nephropathy
@en
Glomerular permselectivity in early stages of overt diabetic nephropathy
@nl
type
label
Glomerular permselectivity in early stages of overt diabetic nephropathy
@ast
Glomerular permselectivity in early stages of overt diabetic nephropathy
@en
Glomerular permselectivity in early stages of overt diabetic nephropathy
@nl
prefLabel
Glomerular permselectivity in early stages of overt diabetic nephropathy
@ast
Glomerular permselectivity in early stages of overt diabetic nephropathy
@en
Glomerular permselectivity in early stages of overt diabetic nephropathy
@nl
P2093
P1433
P1476
Glomerular permselectivity in early stages of overt diabetic nephropathy
@en
P2093
P304
P356
10.1111/J.1523-1755.2000.00386.X
P407
P50
P577
2000-11-01T00:00:00Z
P5875
P6179
1031002212